# Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis

> **NCT03597620** · PHASE4 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 11 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Metaderm

## Key facts

- **NCT ID:** NCT03597620
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-07
- **Primary completion:** 2020-10-31
- **Final completion:** 2022-12-13
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03597620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03597620, "Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03597620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*